血液バンキング機器市場：採血機器、血液処理機器、血液保存機器、地域別、2026～2032年

血液バンキング機器市場の評価-2026-2032

がんや貧血のような疾病の増加により、頻繁な輸血が必要となり、血液バンキング機器の採用を促進しています。人口の高齢化は、血液製剤や血液バンキングサービスの需要増につながり、市場規模は2024年に452億8,000万米ドルを突破し、2032年には約848億米ドルの評価額に達します。

これに加えて、血液保管・保存技術の革新が、血液バンキングプロセスの効率性と安全性を高めています。複雑な手術や緊急手術を含む手術件数の増加により、市場は2026年から2032年にかけてCAGR 9.00%で成長します。

血液バンキング機器市場定義/概要

血液バンキング機器は、血液および血液成分の収集、処理、検査、保管、流通に使用される特殊な医療機器です。これらの機器は、輸血やその他の医療目的のために血液の生存率を維持するため、血液の安全な取り扱いと保存を保証します。主な装置には、採血バッグ、冷蔵庫および冷凍庫、血液混合機、遠心分離機、血液バンク分析装置などがあります。

血液バンキング機器は、主に血液バンク、病院、診断センター、研究所で使用されます。ドナーからの採血、赤血球、血漿、血小板などのさまざまな血液成分の分離・保存、血液の安全性を確保するための感染症検査などで重要な役割を果たしています。これらの装置はまた、血漿交換や自己血輸血などの治療手順をサポートし、様々な病状、手術、緊急事態における患者のケアに不可欠です。

技術の進歩はどのように血液バンキング機器の採用を増加させるか？

血液バンキング機器市場は、様々な医療処置における血液および血液成分の需要の増加により、著しい成長を遂げています。慢性疾患の罹患率の上昇、外科手術の増加、血液収集・保存技術の進歩などの要因が、市場拡大に拍車をかけています。世界保健機関（WHO）によると、2018年には世界で1億1,850万件の献血が行われ、血液バンキング業務の規模の大きさが浮き彫りになりました。2024年4月、テルモ株式会社は新しい自動血液成分分離装置の発売を発表し、血液処理の効率を高め、市場拡大に貢献しています。

血液バンキング機器における技術的進歩は主要な促進要因であり、革新は採血、処理、保管における安全性、効率性、自動化の改善に焦点を当てています。これらの開発は、血液製剤の品質と安全性を確保しつつ、増大する需要を満たす上で極めて重要です。米国食品医薬品局は、2019年に米国で1,360万単位以上の全血および赤血球が採取されたと報告しました。2024年1月、Haemonetics Corporationは血液センター管理のための新しいソフトウェアプラットフォームを導入し、血液バンキングプロセスにおける業務の合理化とトレーサビリティの強化を実現しました。

血液疾患の有病率の増加や外傷症例の増加も、血液バンキング機器の需要を押し上げています。世界中のヘルスケア・システムが緊急事態への備えの向上に努める中、適切な血液供給を維持することに注目が集まっています。米国赤十字社によると、米国では2秒に1人が血液を必要としており、効率的な血液バンキングシステムが常に必要とされています。2024年3月、フレゼニウス・カビは血小板のための新しい病原体減少技術を発表し、輸血による感染症の懸念に対処し、血液バンキング機器の市場を拡大する可能性があります。

血液バンキング機器のサイバーセキュリティとコストはその応用を抑制するか？

血液バンキング機器市場の主な抑制要因の1つは、高度な血液バンキング機器や技術に関連する高コストです。特に発展途上国では、多くの病院や血液バンキング機器が予算の制約に直面しており、最新機器への投資が制限されています。初期購入費、メンテナンス費、運用費が高額になるため、小規模なヘルスケア施設ではこれらの技術を採用できず、市場の成長が抑制される可能性があります。

もう一つの大きな課題は、血液バンキング機器を取り巻く厳しい規制環境です。FDAやEMAのような保健当局が課す数多くの規制や基準を確実に遵守するためには、かなりの時間と財政的投資が必要となります。規制遵守を維持するための継続的な更新や監査の必要性は、メーカーや医療提供者にとって負担となり、市場における新技術やイノベーションの採用を遅らせる可能性があります。

一般市民やヘルスケア専門家の間で、献血や高度な血液バンキング機器技術の重要性に対する認識や教育が限定的であることも課題となっています。多くの地域では、高度な血液バンキング機器の使用に関するヘルスケア従事者への十分なトレーニングが行われていないため、これらの技術が十分に活用されていないです。さらに、献血に対する誤解や恐怖心がドナー募集の妨げとなり、血液供給が不十分となり、血液バンキング業務の効果に影響を与えています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 血液バンキング機器市場：採血機器別

• 針と注射器
• 血液バッグ
• 採血管

第5章 血液バンキング機器市場：血液処理装置別

• 遠心分離機
• フィルター
• 血液分析装置

第6章 血液バンキング機器市場：タイプ別

• 冷蔵庫および冷凍庫
• 血液バンク用冷蔵庫

第7章 血液バンキング機器市場：血液保存機器別

• 冷蔵庫および冷凍庫
• 血液バンク用冷蔵庫

第8章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第9章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第10章 競合情勢

• 主要企業
• 市場シェア分析

第11章 企業プロファイル

• Terumo Corporation
• Fresenius Kabi
• Haemonetics Corporation
• Grifols S.A.
• Macopharma
• Becton, Dickinson and Company（BD）
• Beckman Coulter, Inc.（Danaher Corporation）
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics
• Sartorius AG
• Siemens Healthineers AG
• Mediware Information Systems, Inc.
• Cerus Corporation
• LivaNova PLC
• MacoPharma SA
• Kawasumi Laboratories, Inc.
• China Biologic Products Holdings, Inc.

第12章 市場展望市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第13章 付録

• 略語リスト
• 出典と参考文献

Blood Banking Devices Market Valuation - 2026-2032

Increased incidences of diseases like cancer and anemia necessitate frequent blood transfusions is propelling the adoption of blood banking devices. An aging population leads to higher demand for blood products and blood banking services is driving the market size surpass USD 45.28 Billion valued in 2024 to reach a valuation of around USD 84.8 Billion by 2032.

In addition to this, innovations in blood storage and preservation technologies enhance the efficiency and safety of blood banking processes. The increasing number of surgeries, including complex and emergency procedures are enabling the market to grow at a CAGR of 9.00% from 2026 to 2032.

Blood Banking Devices Market: Definition/ Overview

Blood banking devices are specialized medical equipment used for the collection, processing, testing, storage, and distribution of blood and blood components. These devices ensure the safe handling and preservation of blood to maintain its viability for transfusions and other medical purposes. Key devices include blood collection bags, refrigerators and freezers, blood mixers, centrifuges, and blood bank analyzers.

Blood banking devices are primarily used in blood banks, hospitals, diagnostic centers, and research laboratories. They play a critical role in blood collection from donors, separating and storing different blood components like red cells, plasma, and platelets, and testing for infectious diseases to ensure blood safety. These devices also support therapeutic procedures such as plasma exchange and autologous blood transfusion, which are vital for patient care in various medical conditions, surgeries, and emergencies.

How will Technological Advancements Increase Adoption of Blood Banking Devices?

The blood banking devices market is experiencing significant growth, driven by increasing demand for blood and blood components in various medical procedures. Factors such as rising incidence of chronic diseases, growing number of surgical procedures, and advancements in blood collection and storage technologies are fueling market expansion. According to the World Health Organization, 118.5 million blood donations were collected globally in 2018, highlighting the scale of blood banking operations. In April 2024, Terumo Corporation announced the launch of its new automated blood component separator, enhancing efficiency in blood processing and contributing to market growth.

Technological advancements in blood banking devices are a major driver, with innovations focusing on improving safety, efficiency, and automation in blood collection, processing, and storage. These developments are crucial in meeting the growing demand for blood products while ensuring their quality and safety. The U.S. Food and Drug Administration reported that over 13.6 million units of whole blood and red blood cells were collected in the United States in 2019. In January 2024, Haemonetics Corporation introduced a new software platform for blood center management, streamlining operations and enhancing traceability in blood banking processes.

The increasing prevalence of blood disorders and the rising number of trauma cases are also driving the demand for blood banking devices. As healthcare systems worldwide strive to improve emergency preparedness, there's a growing focus on maintaining adequate blood supplies. According to the American Red Cross, someone in the U.S. needs blood every two seconds, underscoring the constant need for efficient blood banking systems. In March 2024, Fresenius Kabi unveiled a new pathogen reduction technology for platelets, addressing concerns about transfusion-transmitted infections and potentially expanding the market for blood banking devices.

Will Cybersecurity and Costs of Blood Banking Devices Restrain Its Application?

One of the primary restraints of the blood banking devices market is the high cost associated with advanced blood banking equipment and technologies. Many hospitals and blood banks, especially in developing countries, face budget constraints that limit their ability to invest in the latest devices. The initial purchase, maintenance, and operational costs can be prohibitive, preventing smaller healthcare facilities from adopting these technologies and thereby restricting market growth.

Another significant challenge is the stringent regulatory environment surrounding blood banking devices. Ensuring compliance with numerous regulations and standards imposed by health authorities like the FDA and EMA requires considerable time and financial investment. The need for continuous updates and audits to maintain regulatory compliance can be burdensome for manufacturers and healthcare providers, potentially slowing the adoption of new technologies and innovations in the market.

Limited awareness and education about the importance of blood donation and advanced blood banking technologies among the general public and healthcare professionals also pose a challenge. In many regions, there is a lack of adequate training for healthcare workers on the use of sophisticated blood banking devices, leading to suboptimal utilization of these technologies. Additionally, misconceptions and fears about blood donation can hinder donor recruitment efforts, resulting in insufficient blood supply and impacting the effectiveness of blood banking operations.

Category-Wise Acumens

Will Rise in Adoption of Centrifuges Drive Blood Banking Devices Market?

Centrifuges are dominating the blood banking devices market, playing a crucial role in the separation and processing of blood components. These devices are essential for isolating platelets, plasma, and red blood cells from whole blood, enabling efficient storage and targeted transfusion therapies. The increasing demand for blood components in various medical procedures, coupled with advancements in centrifuge technology, is driving market growth. According to the World Health Organization, over 117.4 million blood donations are collected globally each year, with a significant portion processed using centrifuges. In February 2024, Thermo Fisher Scientific launched a new high-capacity blood bank centrifuge, capable of processing up to 12 units of whole blood simultaneously.

The efficiency and reliability of centrifuges in blood component separation have made them indispensable in blood banks and transfusion centers. Modern centrifuges offer features such as automated balancing, temperature control, and programmable protocols, enhancing the quality and consistency of blood components. The U.S. Food and Drug Administration reported that in 2020, approximately 10.2 million units of whole blood were collected in the United States, with most undergoing centrifugation for component separation. In April 2024, Beckman Coulter announced the integration of artificial intelligence into their latest blood bank centrifuge, optimizing separation parameters based on individual sample characteristics.

Centrifuges are also playing a vital role in addressing global health challenges, including the management of blood supplies during pandemics and natural disasters. The ability to quickly process large volumes of blood donations is critical in emergency situations. According to the American Red Cross, every two seconds someone in the U.S. needs blood, emphasizing the constant need for efficient blood processing. In January 2024, Haemonetics Corporation introduced a new centrifuge designed specifically for small and mobile blood collection centers, improving access to blood banking capabilities in remote areas and during emergencies.

Will Rise in Adoption of Blood Collection Tubes Drive Blood Banking Devices Market?

Blood collection tubes are emerging as a dominant force in the blood banking devices market, playing a crucial role in the safe and efficient collection, storage, and transportation of blood samples. These tubes, available in various types with specific additives, ensure the integrity of blood samples for accurate testing and processing. The increasing demand for blood diagnostics, coupled with the rise in chronic diseases and surgical procedures, is driving the growth of blood collection tubes. According to the Centers for Disease Control and Prevention (CDC), over 7 billion clinical lab tests are performed annually in the United States, with a significant portion involving blood samples. In March 2024, BD (Becton, Dickinson and Company) launched a new line of eco-friendly blood collection tubes, addressing sustainability concerns in healthcare.

The advancements in blood collection tube technology have significantly improved sample quality and reduced contamination risks, making them indispensable in modern blood banking. These tubes now feature innovations such as improved additive formulations, enhanced barrier gels, and specialized coatings to maintain sample stability. The World Health Organization reported that in 2020, approximately 118 million blood donations were collected globally, highlighting the massive scale of blood collection tube usage. In January 2024, Greiner Bio-One International GmbH introduced a new vacuum blood collection tube with extended stability for rare blood type samples, addressing a critical need in specialized blood banking.

Country/Region-wise Acumens

Will Advanced Healthcare Infrastructure in North America Drive Blood Banking Devices Market Growth?

North America is dominating the blood banking devices market owing to advanced healthcare infrastructure, high adoption rates of new technologies, and a well-established blood donation system. The region's robust research and development activities in blood banking technologies contribute significantly to market growth. According to the American Red Cross, approximately 36,000 units of red blood cells are needed every day in the United States, underlining the constant demand for efficient blood banking devices. In February 2024, Abbott Laboratories launched a new automated blood and plasma screening system in the U.S., enhancing the efficiency and safety of blood testing processes.

The presence of major market players and supportive government initiatives further strengthen North America's position in the blood banking devices market. These factors have led to the development and implementation of cutting-edge technologies in blood collection, processing, and storage. The U.S. Food and Drug Administration reported that in 2022, over 15.7 million units of whole blood and red blood cells were collected in the country, highlighting the scale of blood banking operations. In April 2024, Terumo BCT announced the expansion of its manufacturing facility in Colorado, aiming to increase production capacity for blood component collection and processing systems.

Will Rising Demand for Blood and Blood Components Enhance Adoption of Blood Banking Devices in Asia Pacific?

The Asia Pacific blood banking devices market is experiencing rapid growth, driven by increasing demand for blood and blood components in healthcare settings. According to the World Health Organization, the region collected approximately 83 million blood donations in 2021, representing a 10% increase from 2018. This growth is attributed to rising healthcare expenditure, improving healthcare infrastructure, and a growing awareness of blood donation. Key players like Terumo Corporation and Haemonetics Corporation have been expanding their presence in the region to capitalize on this growth.

Technological advancements in blood banking devices are further propelling market growth. The Indian Council of Medical Research reported that the adoption of automated blood component separators increased by 35% between 2019 and 2024 in India alone. In February 2024, Japanese company Sysmex Corporation launched its new XN-31 automated hematology analyzer in Southeast Asian markets, offering improved efficiency in blood cell analysis. This innovation highlights the industry's focus on enhancing blood testing accuracy and efficiency to meet the growing demand for blood products.

Competitive Landscape

The blood banking devices market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the blood banking devices market include:

• Terumo Corporation
• Fresenius Kabi
• Haemonetics Corporation
• Grifols S.A.
• Macopharma
• Becton, Dickinson and Company (BD)
• Beckman Coulter, Inc. (Danaher Corporation)
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics
• Sartorius AG
• Siemens Healthineers AG
• Mediware Information Systems, Inc.
• Cerus Corporation
• LivaNova PLC
• MacoPharma SA
• Kawasumi Laboratories, Inc.
• China Biologic Products Holdings, Inc.

Latest Developments

• In September 2024, Terumo Blood and Cell Technologies launched a new automated blood collection system that features enhanced user interface and advanced blood processing capabilities for increased efficiency.
• In August 2024, Haemonetics Corporation introduced a state-of-the-art blood centrifuge with improved separation technology, offering higher yield and better quality of blood components.

Blood Banking Devices Market, By Category

• Blood Collection Devices:
• Needles and Syringe
• Blood Bags
• Blood Collection Tubes
• Blood Processing Devices:
• Centrifuges
• Filters
• Hematology Analyzers
• Blood Storage Devices:
• Refrigerators and Freezers
• Blood Bank Refrigerators
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Blood Banking Devices Market, By Blood Collection Devices

• Needles and Syringes
• Blood Bags
• Blood Collection Tubes

5. Blood Banking Devices Market, By Blood Processing Devices

• Centrifuges
• Filters
• Hematology Analyzers

6. Blood Banking Devices Market, By Type

• Refrigerators and Freezers
• Blood Bank Refrigerators

7. Blood Banking Devices Market, By Blood Storage Devices

• Refrigerators and Freezers
• Blood Bank Refrigerators

8. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

9. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

10. Competitive Landscape

• Key Players
• Market Share Analysis

11. Company Profiles

• Terumo Corporation
• Fresenius Kabi
• Haemonetics Corporation
• Grifols S.A.
• Macopharma
• Becton, Dickinson and Company (BD)
• Beckman Coulter, Inc. (Danaher Corporation)
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics
• Sartorius AG
• Siemens Healthineers AG
• Mediware Information Systems, Inc.
• Cerus Corporation
• LivaNova PLC
• MacoPharma SA
• Kawasumi Laboratories, Inc.
• China Biologic Products Holdings, Inc.

12. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

13. Appendix

• List of Abbreviations
• Sources and References